Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-Hodgkin B-cell lymphoma risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 2, 2013, Pages 295-307

  Hussain, Shehnaz K ^a,b   Zhu, Weiming ^a   Chang, Shen Chih ^a   Breen, Elizabeth Crabb ^b   Vendrame, Elena ^b   Magpantay, Larry ^b   Widney, Dan ^b   Conn, Daniel ^a   Sehl, Mary ^b   Jacobson, Lisa P ^c   Bream, Jay H ^d   Wolinsky, Steven ^f   Rinaldo, Charles R ^g   Ambinder, Richard F ^e   Detels, Roger ^a   Zhang, Zuo Feng ^a,b   Martínez Maza, Otoniel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c David Geffen School of Medicine at UCLA ^*  (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER RISK; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NONHODGKIN B CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINE CXCL13; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CXCR5; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84873374765     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1122     Document Type: Article

References (64)

1. Grulich AE, Li YM, McDonald AM, Correll PK, Law MG, Kaldor JM. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination antiretroviral therapy. AIDS 2001;15:629-33.
2. Epeldegui M, Widney DP, Martinez-Maza O. Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions. Curr Opin Oncol 2006;18:444-8.
3. Martinez-Maza O, Breen EC. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 2002;14:528-32.
4. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
5. Amadori A, Zamarchi R, Ciminale V, Delmistro A, Siervo S, Alberti A, et al. HIV-1-specific Bcell activation - a major constituent of spontaneous b-cell activation during HIV-1 infection. J Immunol 1989;143:2146-52.
6. Amadori A, Chiecobianchi L. B-cell activation and HIV-1 infection - deeds and misdeeds. Immunol Today 1990;11:374-9.
7. Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. Membrane tumor-necrosis-factor-alpha is involved in the polyclonal B-cell activation-induced by HIV-infected human T-cells. Nature 1993;363:464-6.
8. Martinezmaza O, Crabb E, Mitsuyasu RT, Fahey JL, Giorgi JV. Infection with the human-immunodeficiency-virus (HIV) is associated with an in vivo increase in lymphocyte-B activation and immaturity. J Immunol 1987;138:3720-4.
9. Xu ZM, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P. Regulation of aicda expression and AID activity: Relevance to somatic Hypermutation and class switch DNA recombination. Crit Rev Immunol 2007;27:367-97.
10. Okazaki I, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, et al. Constitutive expression of AID leads to tumorigenesis. J Exp Med 2003;197:1173-81.
11. Komeno Y, Kitaura J, Watanabe-Okochi N, Kato N, Oki T, Nakahara F, et al. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model. Leukemia 2010;24:1018-24.
12. Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, et al. B-Cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev 2011;20:1303-14.
13. Przybylski GK, Goldman J, Ng VL, McGrath MS, Herndier BG, Schenkein DP, et al. Evidence for early B-Cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 1996;88:4620-9.
14. Fisher SG, Fisher RI. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 2006;18:417-24.
15. Grulich AE, Wan XN, Law MG, Milliken ST, Lewis CR, Garsia RJ, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000;14:133-40.
16. Landgren O, Goedert JJ, Rabkin CS, Wilson WH, Dunleavy K, Kyle RA, et al. Circulating serum free light chains as predictive markers of AIDSrelated lymphoma. J Clin Oncol 2010;28:773-9.
17. Rabkin CS, Engels EA, Landgren O, Schuurman R, Camargo MC, Pfeiffer R, et al. Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma. Am J Hematol 2011;86:875-8.
18. Purdue MP, Lan Q, Martinez-Maza O, Oken MM, Hocking W, Huang WY, et al. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood 2009;114:2730-2.
19. Takagi R, Higashi T, Hashimoto K, Nakano K, Mizuno Y, Okazaki Y, et al. B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones. J Immunol 2008;181:186-9.
20. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-14.
21. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 1998;187:655-60.
22. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002;416:94-9.
23. Forster R, Schweigard G, Johann S, Emrich T, Kremmer E, Nerl C, et al. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood 1997;90:520-5.
24. Cagigi A, Mowafi F, Dang L V P, Tenner-Racz K, Atlas A, Grutzmeier S, et al. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 2008;112:4401-10.
25. Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 2005;25:702-6.
26. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1037-47.
27. Widney DP, Gui D, Popoviciu LM, Said JW, Breen EC, Huang X, et al. Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in Aids-associated non-Hodgkin's lymphoma. AIDS Res Treat 2010;164586:25.
28. Deutsch A J A, Agelsreiter A, Steinbauer E, Fruhwirth M, Kerl H, Behann-Schmid C, et al. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 2008;215:431-44.
29. Smith JR, Braziel RM, Paoletti S, Lipp M, Uguccioni M, Rosenbaum JT. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003;101:815-21.
30. Chan CC, Shen DF, Hackett JJ, Buggage RR, Tuaillon N. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary Intraocular lymphoma. Ophthalmology 2003;110:421-6.
31. Husson H, Freedman AS, Cardoso AA, Schultze J, Munoz O, Strola G, et al. CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. Br J Haematol 2002;119:492-5.
32. Brunn A, Montesinos-Rongen M, Strack A, Reifenberger G, Mawrin C, Schaller C, et al. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathol 2007;114:271-6.
33. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999;104:R49-R54.
34. Ortonne N, Dupuis J, Plonquet A, Martin N, Copie-Bergman C, Bagot M, et al. Characterization of CXCL13 (+) neoplastic T cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol 2007;31:1068-76.
35. Kurtova AV, Tamayo AT, Ford RJ, Burger JA. Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting. Blood 2009;113:4604-13.
36. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, et al. Pathway analysis of primary central nervous system lymphoma. Blood 2008;111:3200-10.
37. Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004;104:502-8.
38. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The multicenter AIDS cohort study - retention after 9-1/2 years. Am J Epidemiol 1995;142:323-30.
39. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The multicenter AIDS cohort study - rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
40. Silvestre AJ, Hylton JB, Johnson LM, Houston C, Witt M, Jacobson L, et al. Recruiting minority men who have sex with men for HIV research: Results from a 4-city campaign. Am J Public Health 2006;96:1020-7.
41. Detels R, Jacobson L, Margolick J, Martinez-Maza O, Muñoz A, Phair J, et al. The multicenter AIDS Cohort Study, 1983 to.... Public Health 2012;126:196-8.
42. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents: Henry J Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection; October 2004 Revision. http://www.aidsinfo.nih.gov.
43. Giorgi JV, Cheng H-L, Margolick JB, Bauer KD, Ferbas J, Waxdal M, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experience. Clin Immunol Immunopathol 1990;55:173-86.
44. Murray PG, Constandinou CM, Crocker J, Young LS, Ambinder RF. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. Blood 1998;92:2477-83.
45. Vendrame E, Hussain SK, Breen EC, Magpantay L, Widney DP, Jacobson LP, et al. Cytokines and biomarkers associated with inflammation and immune activation are elevated preceding the diagnosis of AIDS-associated non-Hodgkin B cell lymphoma. In press.
46. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P. A haplotype map of the human genome. Nature 2005;437:1299-320.
47. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20.
48. Desai M, Kubo J, Esserman D, Terry MB. The Handling of Missing Data in Molecular Epidemiology Studies. Cancer Epidemiol Biomarkers Prev 2011;20:1571-9.
49. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001;194:45-56.
50. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 2001;44:2633-41.
51. Wilke CM, Bishop K, Fox D, Zou WP. Deciphering the role of Th17 cells in human disease. Trends Immunol 2011;32:603-11.
52. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor ROR gamma t directs the differentiation program of proinflammatory IL-17 (+) T helper cells. Cell 2006;126:1121-33.
53. Galand C, Donnou S, Crozet L, Brunet S, Touitou V, Ouakrim H, et al. Th17 Cells are involved in the local control of tumor progression in primary intraocular lymphoma. PloS ONE 2011;6:e24622.
54. Louten J, Boniface K, Malefyt RD. Development and function of T (H) 17 cells in health and disease. J Allergy Clin Immunol 2009;123:1004-11.
55. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-71.
56. Marchetti G, Cozzi-Lepri A, Merlini E, Bellistri GM, Castagna A, Galli M, et al. Microbial translocation predicts disease progression of HIVinfected antiretroviral-naive patients with high CD4 (+) cell count. AIDS 2011;25:1385-94.
57. Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010;201:1150-4.
58. Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, et al. Effect of highly active antiretroviral therapy on biomarkers of Blymphocyte activation and inflammation. AIDS 2011;25:303-14.
59. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-U3.
60. Xu ZL, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37:W600-W5.
61. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999;93:1838-42.
62. O'Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev 2000;177:99-111.
63. Song H, Tong D, Cha Z, Bai J. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma. Mol Biol Rep 2012;39:8629-35.
64. Mellors JW, Margolick JB, Phair JP, Rinaldo CR, Detels R, Jacobson LP, et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 2007;297:2349-50.